BioSpace News Archive

Business

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results

Helix BioPharma Corp., a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, announced its financial results for the fiscal third quarter ended April 30, 2021.

June 14, 2021
·
15 min read
FDA

The U.S. FDA Approved IND Application to Investigate Combination of Asieris’ APL-1202 and BeiGene’s Tislelizumab as Neoadjuvant Therapy for MIBC Patients

Asieris Pharmaceuticals (Asieris) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application of oral APL-1202 in combination with BeiGene’s tislelizumab as neoadjuvant therapy in patients with muscle invasive bladder cancer (MIBC).

June 14, 2021
·
4 min read
FDA

Jasper Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for JSP191 for Conditioning Treatment Prior to Stem Cell Transplant

Jasper Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to JSP191, a monoclonal antibody targeting the CD117 (stem cell factor) receptor.

June 14, 2021
·
5 min read
BioForest

Omeros’ Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 2021 Annual Congress of the European Hematology Association

Omeros Corporation (Nasdaq: OMER) today announced that data on organ function improvement from its pivotal trial of narsoplimab were shared during an oral presentation at the virtual edition of the 26th Congress of the European Hematology Association (EHA).

June 14, 2021
·
6 min read
Genetown

Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting

Lantheus Holdings, Inc. announced that data from the piflufolastat F 18 (formerly known as 18 F-DCFPyL) CONDOR pivotal trial will be presented at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 14, 2021
·
7 min read
Drug Development

New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer

Veracyte, Inc. today announced new data demonstrating the prognostic utility of the company’s Decipher® Prostate genomic classifier among men with non-metastatic castration-resistant prostate cancer (nmCRPC) have been published online in JAMA Oncology.

June 14, 2021
·
7 min read
Deals

Synaptogenix Announces $12.5 Million Private Placement

Synaptogenix, Inc. today announced that it has executed securities purchase agreements to raise gross proceeds of approximately $12.5 million in a private placement financing of common stock and warrants (“Units”).

June 14, 2021
·
4 min read
Press Releases

Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

Sana Biotechnology, Inc. today announced that data will be presented during two plenary sessions at the International Society for Stem Cell Research 2021 Virtual Annual Meeting, to be held Monday, June 21 through Saturday, June 26.

June 14, 2021
·
4 min read
BioMidwest

First Patient Enrolled in Restrata® Randomized Controlled Trial

Acera Surgical, Inc. today announced its first patient enrollment in a clinical study evaluating Restrata, Acera’s leading wound care product, for the treatment of non-healing diabetic foot ulcers.

June 14, 2021
·
3 min read
Business

Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology

Labcorp (NYSE: LH), and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Cancer Center, today announced the launch of OmniSeq INSIGHT℠, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (NGS) technology.

June 14, 2021
·
4 min read